| |
| |
|
| Insider
Information: |
Kroin David |
| Relationship: |
|
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,520,114 |
|
|
Indirect Shares
|
31,413,796 |
|
|
| Direct
Value |
$64,190,480 |
|
|
|
Indirect Value
|
$138,024,281 |
|
|
| Total
Shares |
32,933,910 |
|
|
| Total
Value |
$202,214,761 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -400.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Albireo Pharma Inc |
ALBO |
Director |
2009-08-17 |
1,453,918 |
2008-02-12 |
1,812,574 |
Premium* |
|
|
Infusystems Holdings Uts |
HAPUE |
10% Owner |
|
0 |
2011-02-10 |
0 |
Premium* |
|
|
Connecture Inc |
CNXR |
10% Owner |
2015-06-30 |
66,196 |
2015-06-30 |
4,203,163 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
10% Owner |
|
0 |
2017-06-21 |
2,216,351 |
Premium* |
|
|
Foamix Pharmaceuticals Ltd |
FOMX |
10% Owner |
|
0 |
2017-04-10 |
4,781,708 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
|
|
0 |
2024-03-05 |
18,400,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
|
– – • |
2024-03-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,400,000 |
|
% |
|
| ADMS |
Adamas Pharmaceuticals In... |
10% Owner |
– – • |
2017-06-21 |
4 |
S |
$17.44 |
$174,365 |
I/I |
(10,000) |
2,216,351 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
10% Owner |
– – • |
2017-06-20 |
4 |
S |
$17.35 |
$346,934 |
I/I |
(20,000) |
2,231,351 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
10% Owner |
– – • |
2017-06-19 |
4 |
S |
$17.05 |
$5,967,675 |
I/I |
(350,000) |
2,251,351 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
10% Owner |
– – • |
2017-04-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,781,708 |
|
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
10% Owner |
– – • |
2016-07-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,601,351 |
|
- |
|
| CNXR |
Connecture Inc |
10% Owner |
– – • |
2015-06-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
29,703 |
0 |
- |
|
| CNXR |
Connecture Inc |
10% Owner |
– – • |
2015-06-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,375,733) |
4,127,232 |
0 |
- |
|
| CNXR |
Connecture Inc |
10% Owner |
– – • |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
I/I |
75,931 |
28,696 |
0 |
- |
|
| CNXR |
Connecture Inc |
10% Owner |
– – • |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
76,196 |
36,493 |
0 |
- |
|
| CNXR |
Connecture Inc |
10% Owner |
– – • |
2014-12-17 |
4 |
S |
$8.00 |
$3,167,088 |
I/I |
(395,886) |
5,502,965 |
0 |
- |
|
| CNXR |
Connecture Inc |
10% Owner |
– – • |
2014-12-17 |
4 |
A |
$0.00 |
$0 |
I/I |
5,898,851 |
5,898,851 |
0 |
- |
|
| HAPUE |
Infusystems Holdings Uts |
10% Owner |
– – • |
2011-02-10 |
4 |
S |
$2.23 |
$9,464,325 |
I/I |
(4,250,000) |
0 |
0 |
- |
|
| HAPUE |
Infusystems Holdings Uts |
10% Owner |
– – • |
2011-02-08 |
4 |
S |
$2.75 |
$687,500 |
I/I |
(250,000) |
420,710 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-08-17 |
4 |
AS |
$5.00 |
$2,595 |
D/D |
(519) |
1,453,918 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-08-14 |
4 |
AS |
$5.02 |
$24,598 |
D/D |
(4,900) |
1,454,437 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-08-05 |
4 |
AS |
$5.00 |
$6,500 |
D/D |
(1,300) |
1,472,515 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-08-04 |
4 |
AS |
$5.01 |
$32,064 |
D/D |
(6,400) |
1,473,815 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-08-03 |
4 |
AS |
$5.05 |
$2,020 |
D/D |
(400) |
1,480,215 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-07-31 |
4 |
AS |
$5.02 |
$6,526 |
D/D |
(1,300) |
1,480,615 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-07-24 |
4 |
AS |
$5.23 |
$116,394 |
D/D |
(22,255) |
1,508,015 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-07-23 |
4 |
AS |
$5.21 |
$295,407 |
D/D |
(56,700) |
1,530,270 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-07-22 |
4 |
AS |
$5.24 |
$168,204 |
D/D |
(32,100) |
1,586,970 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-07-21 |
4 |
AS |
$5.20 |
$97,396 |
D/D |
(18,730) |
1,619,070 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2009-07-20 |
4 |
AS |
$5.05 |
$36,360 |
D/D |
(7,200) |
1,637,800 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
